Glycomine www.glycomine.com
26 employees on LinkedIn · 7 known investors
Find your way into Glycomine www.glycomine.com
611 people in our graph share verified history with the Glycomine www.glycomine.com team — schools, employers, funds. One of them is your warm intro.
Stacey Herounlockedknows Geoffrey Hird · together at Duke University (overlapped)
knows the team · via University of Toronto
×4knows the team · via Duke University
knows the team · via University of North Carolina at Chapel Hill
knows the team · via Merck KGaA, Darmstadt, Germany
×4knows the team · via William & Mary
Glycomine develops therapeutics for rare diseases, many of which currently lack disease-modifying treatment options. The company focuses on addressing unmet medical needs in the rare disease space.
Founders & leadership
SA
Steven AxoninChief Executive OfficerSteven Axon is CEO of Glycomine, which develops therapeutics for rare diseases. He has background in biotech business development, corporate strategy, and corporate finance.
HA
Hicham AlaouiinChief Scientific OfficerHicham Alaoui is Chief Scientific Officer of Glycomine, a company developing therapeutics for rare diseases. He has led drug discovery and development programs for small molecules and biologics at Genentech and has experience advancing clinical candidates across multiple therapeutic areas with unmet medical needs.
RM
Rose MarinoinChief Medical Officer
PM
GH
Geoffrey HirdinChief Technology OfficerGeoffrey Hird is Chief Technology Officer at Glycomine, a therapeutics company developing treatments for rare diseases. With 19 years of experience across small, medium, and large pharmaceutical companies, he has led CMC teams in drug product development and manufacturing, with expertise in surfactant science and formulation technologies including liposomes, lipid nanoparticles, and inhaled and oral delivery systems.
Investors · 7
Competitors · 2
by search overlapMyriad10 shared keywordsMyriad provides germline and tumor genomic testing across hereditary cancer, prenatal and reproductive health, prostate cancer, and pharmacogenomics for mental health medications. It supplies patients and healthcare providers with genetic screening results and AI-derived insights to inform diagnosis, risk assessment, and treatment decisions.
Eli Lilly9 shared keywordsEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.
Companies competing with Glycomine www.glycomine.com for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Glycomine www.glycomine.com do?
- Glycomine develops therapeutics for rare diseases, many of which currently lack disease-modifying treatment options. The company focuses on addressing unmet medical needs in the rare disease space.
- Who are Glycomine www.glycomine.com's investors?
- Glycomine www.glycomine.com's investors include Advent Life Sciences, Mission Bay Capital, Mission Biocapital, Remiges Ventures, Inc., RiverVest Venture Partners, Sanderling Ventures, Sanofi Ventures.